Background: Because small colonic tumours may not be visualized or palpated during laparoscopy, location of the lesion must be identified before surgery. The aim of this study was to evaluate the effectiveness of the current recommendation of endoscopic tattooing of lesions prior to laparoscopic colonic resections.
A bout 100 000 cases of colon cancer are now diag nosed each year in the United States, and most are amenable to resection with curative intent. 1 In the past decade, there has been a dramatic shift in practice toward minimally invasive surgery, with an increasing number of laparoscopic colon resections being performed. Since laparoscopic surgery is associated with decreased tac tile feedback, 2 small colonic lesions may not be detectable intraoperatively. Failure to accurately localize a tumour may lead to adverse outcomes, including resection of a wrong segment of bowel, positive resection margins, con version to open surgery, ontable colonoscopy, or ontable alteration in planned surgical resection. In fact, according to a survey conducted by the American Society of Colon and Rectal Surgeons, 6 .5% of surgeons who perform rou tine laparoscopic colonic resection have admitted to removing the wrong segment of bowel at least once. 3 Colonoscopy is firmly established as the gold standard both for diagnosis and preoperative localization of malig nant colonic lesions. However, even colonoscopic tumour localization is inaccurate in 11.3%-21% of cases. [4] [5] [6] As such, colonoscopic tattooing is now considered to be stan dard practice for tumour localization before laparoscopic colorectal excision. 7, 8 Several medical and surgical associa tions and societies recommend tattooing of suspicious looking lesions without reference to their size. 9, 10 However, there is no established guideline as to when and how to tat too colonic lesions, resulting in varied practices among physicians and hospitals.
The aim of the present study was to evaluate the effec tiveness of the current practice of endoscopic tattooing of lesions before laparoscopic colonic resection at a tertiary care centre.
Methods
We performed a retrospective cohort study on all con secu tive patients who underwent elective laparoscopic resection for a colonic tumour in the period January 2013 to January 2015 at St. Paul's hospital, Vancouver, which is affiliated with the University of British Columbia. We excluded patients with rectal lesions below the peritoneal reflection, as they would be accurately localized by routine magnetic resonance imaging scan. Also excluded were patients who had more than 1 lesion in the colon or who had emergency surgery. No institutional guideline or pro tocol regarding tattooing existed at the time of the study.
Data on baseline patient demographic and clinical char acteristics were obtained. We collected details regarding endoscopic localization of the tumour, tattooing and endo scopic documentation. Charts were reviewed to collect data on operative visualization and localization of lesions and tattoos, planned and performed surgical procedures, changes in surgical plan and operative and postoperative outcomes. We compared patients with and without tat tooed lesions. Visibility and accuracy of the position of the tattoo at surgery was compared with the position stated in the endoscopy report. The research ethics boards of St. Paul's Hospital and the University of British Columbia approved our study.
Statistical analysis
Descriptive statistics are reported, including means, medians, standard deviations and ranges. We used the Student t test or the Mann-Whitney U test to compare means. Categorical variables were compared using the χ 2 test. All statistics were 2tailed, and we considered results to be significant at p < 0.05. Statistical analysis was done with the software package R Studio.
Results
During the study period, 276 patients underwent laparo scopic colonic resection for malignant lesions. We excluded 41 patients because the lesion was localized in the rectum, and we excluded 11 patients because they had more than 1 lesion. Of the 224 patients included in the study analysis, 148 (66.1%) had their lesion tattooed preoperatively and 76 (33.9%) did not. Patients' baseline demographic and clinical characteristics are shown in Table 1 . Table 2 summarizes differences associated with tattoo ing. The greatest proportion of tattooed lesions (45.5%) was in the left colon, whereas most nontattooed lesions (82.9%) were in the right colon. Most preoperative endos copies were performed by gastroenterologists (86.6%), of which 88.7% were done by staff at our tertiary care centre. The remaining endoscopies were performed by surgeons (13.4%). Surgeons were more likely to tattoo the lesion than gastroenterologists (80% v. 63.9%, p = 0.10). There was no statistically significant difference in the tattoo rate between local gastroenterologists and referring gastroen terologists (62.8% v. 72.7%, p = 0.48). For 8 patients, tattoos were carried out during a second endoscopy, as they had not been tattooed on the first endoscopy and it was deemed necessary by the surgeon preoperatively. The endoscopy reports of 44 (19.6%) patients were missing information regarding tattooing and localization of the lesion. There was no difference in the percentage of lesions seen on computed tomography (CT) scan between the 2 groups. Twentythree (15.5%) patients had their lesions tattooed at a site other than distal to the lesion; 16 were tattooed proximally, and 7 were tattooed both prox imally and distally. Table 3 shows the operative outcomes. Overall, endo scopic localization was accurate in 68.8% of tumours. Of the 70 lesions inaccurately localized by endoscopy, 8 were in the upper rectum (described as sigmoid), 8 were in the sigmoid (described as descending colon), 7 were in the descending colon (described as sigmoid), 6 were in the splenic flexure (described as hepatic flexure), 16 were in the transverse colon (4 described as right colon, 4 as descend ing colon and 8 as splenic flexure), 12 were at the hepatic flexure (described as cecum) and 13 were in the cecum (described as hepatic flexure). Endoscopic localization was more accurate in the nontattooed group than in the tat tooed group (82.9% v. 61.5%, p = 0.002). Of the tattooed lesions, 116 (78.5%) were visualized intraoperatively. Of the 32 tattoos that were not visualized, 16 were in the right colon, 1 in the hepatic flexure, 2 in the transverse colon, 3 in the splenic flexure, 3 in the descending colon, 5 in the sigmoid and 2 in the rectosigmoid.
These inaccurate endoscopic localizations led to intra operative changes in surgical plan in 15.2% of patients. The majority of these occurred in the tattooed group (19.6% v. 6.6%, p = 0.018)
Conversion to open surgery owing to inability to locate or feel the lesion occurred in 3 patients. One patient had a hepatic flexure lesion that was not tattooed and was described as localized in the transverse colon at endos copy. Two patients had tattooed lesions that were not visualized at surgery: 1 in the descending colon and 1 in the sigmoid. Intraoperative endoscopy was needed in 7 patients, including 5 patients whose tattoos could not be seen and 2 patients who did not have their lesions tat tooed. All 7 lesions were located in the sigmoid, and the 2 lesions not tattooed were described as being in the descending colon at endoscopy. Only 1 patient had a microscopic positive distal margin. The lesion was located in the sigmoid and had not been tattooed before surgery. There was no significant difference between the tat tooed and nontattooed groups in intraoperative complica tions (1.4% v. 1.3%, p > 0.99), median estimated blood loss (100 mL v. 100 mL, p > 0. 99 
discussion
Colorectal cancer screening has led to a decrease in colorectal cancer mortality and has been adopted in most economically developed countries. Increased use of fecal occult blood testing (FOBT) and fecal immunochemical tests for hemoglobin (FIT) has led to the detection of early and smaller lesions. 11, 12 In our series, just 50% of the lesions were visible on CT scan. With laparoscopic sur gery for colonic resection, accurate preoperative and intraoperative localization of the tumour is mandatory. Tattooing is an appropriate way to assure accurate local ization for small lesions not identified on CT scan. Although a few studies have recommended tattooing the lesion distally and at multiple circumferential sites, 13, 14 no universal guideline has been adopted to ensure standard ized and effective tattooing.
Our study reports an inaccuracy rate of endoscopic local ization of lesions of 31.2%. This rate exceeds others reported in the literature (11%-21%). [4] [5] [6] Our higher inac curacy may be explained by our categorical distinction of the hepatic flexure, ascending colon and cecum as different segments rather than including them all as the right colon. Also, we excluded distal rectal lesions that are accurately localized preoperatively by digital rectal examination and rigid sigmoidoscopy.
Additionally, there is variability in the way tattooing is performed: single versus multiple circumferential, and proximal versus distal versus both. In our study, 72.4% of tattoos were placed at a single spot. There was a signifi cant difference in tattoo visibility rate if the tattoo was placed at a single spot versus multiple spots (70.8% v. 88.6%, p = 0.030). The high rate of singlespot tattoos can, in part, account for the large proportion of tattoos (21.5%) that were not visible at surgery. Also, 23 patients had lesions tattooed at a site other than distally, which could lead to confusion as to lesion location during sur gery, with potential removal of the wrong segment of bowel or positive margin. Furthermore, in our study there was missing information in regards to tattooing for 43 patients, indicating the need for standardized docu mentation of tattooing.
Adverse outcomes resulted from inaccurate lesion local ization in 45 of 224 (20%) patients in our study: 34 patients had an ontable alteration in surgical plan, 3 patients needed conversion to open surgery to localize the lesion, 7 patients required intraoperative endoscopy to confirm location of the tumour and 1 patient whose lesion was not tattooed had a positive microscopic margin. Adverse outcomes may be avoidable with accurate tattoo ing at the preoperative endoscopy.
In our study, 33.9% of the tumours were not tattooed. This number is similar to rates of tattooing reported in the literature. 15 In our study, 80% of the lesions that were not tattooed were localized in the right colon at endoscopy. Likely, endoscopists did not feel that tattooing was needed if the lesion was visualized in proximity to the landmarks of the ileocecal valve and appendiceal orifice. However, in our study, 25 of the 70 inaccurately localized lesions were described as being in the right colon at endoscopy. We recommend that all potentially significant lesions are tat tooed, even those located in the right colon or rectum. Also, if the lesion is not tattooed, we recommend a second colonoscopy be performed to tattoo the lesion if it is not visible on CT scan.
Arguments supporting the recommendation of tattoo ing all cancers and suspicious polyps include safety and low cost. 16 In our series, no complications resulted from endoscopic tattooing. There was also no difference in the number of lymph nodes retrieved or in intraoperative complication rates from tattooing. Shorter duration of sur gery in our nontattooed group was explained by the higher number of rightsided lesions that were not tattooed.
Limitations
Our study was limited by its retrospective design and singleinstitution experience. The decision to tattoo or not tattoo the lesion was at the discretion of the endosco pist, which introduced potential selection bias. Addition ally, absence of standardized endoscopy reporting on tat tooing resulted in missing or incomplete data. Finally, there were no data on the use of a scope guide, which can help with localization of the lesion.
conclusion
To improve surgical planning and outcomes, we recom mend endoscopic tattooing of all cancers and suspicious polyps just distal to the lesion using multiple injections to cover the circumference of the bowel wall as well as recording all pertinent information in the endoscopy report. Every institution should establish clear guidelines to ensure standard practice among endoscopists and to increase accuracy rates.
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